Questcor Pharmacueticals (QCOR) Tops Q2 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Oppenheimer Downgrades Questcor Pharmaceuticals (QCOR) to Perform
July 25, 2014 9:37 AM EDTOppenheimer downgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from Outperform to Perform.
For an analyst ratings summary and ratings history on Questcor Pharmaceuticals click here. For more ratings news on Questcor Pharmaceuticals click here.
Shares of Questcor Pharmaceuticals closed at $96.93 yesterday.
... More


